Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer’s Disease-Reference-Cited by-同舟云学术

Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer’s Disease

Published:2017-08-23 Issue:11 Volume:8 Page:2522-2534
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Yu Yan-Fa¹,Huang Ya-Dan¹,Zhang Chen¹,Wu Xu-Nian¹,Zhou Qian¹,Wu Deyan¹,Wu Yinuo¹,Luo Hai-Bin¹²^ORCID

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, PR China

2. Collaborative Innovation Center of High Performance Computing, National University of Defense Technology, Changsha 410073, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Traditional Chinese Medicine Bureau of Guangdong Province

Guangdong Province

State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00268

Reference49 articles.

1. The prion model for progression and diversity of neurodegenerative diseases

2. Alzheimer’s Association (USA) (2015) World Alzheimer Report 2015,http://news.medlive.cn/uploadfile/20150902/14411602338388.pdf.

3. A Century of Alzheimer's Disease

4. The Cholinergic Hypothesis of Geriatric Memory Dysfunction

5. Current and Emerging Drug Treatment Options for Alzheimerʼs Disease

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease;European Journal of Medicinal Chemistry;2024-12

2. Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease;Ageing Research Reviews;2024-06

3. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

4. An overview of phosphodiesterase 9 inhibitors: Insights from skeletal structure, pharmacophores, and therapeutic potential;European Journal of Medicinal Chemistry;2023-11

5. Virtual Screening-Accelerated Discovery of a Phosphodiesterase 9 Inhibitor with Neuroprotective Effects in the Kainate Toxicity In Vitro Model;ACS Chemical Neuroscience;2023-09-19